1 4 0 1 a r t I C l e S Multiple sclerosis is a T cell-mediated inflammatory demyelinating disease of the human CNS 1 . Inflammatory demyelination is coupled with neurodegeneration in multiple sclerosis, although the precise mechanisms underlying this remain uncertain [2] [3] [4] . Many components of the myelin sheath have been injected into animals to induce EAE. Studies of the EAE model have helped to define the sequence of immunopathogenic events involved in the development of autoimmune CNS-directed inflammatory diseases 5 . During the initiation stage of EAE, in addition to T cell activation and expansion, antigenpresenting cells (APCs) produce cytokines to regulate the differentiation of effector CD4 T cells, including the classical Th1 (producing interferon-γ (IFNγ) and tumor necrosis factor α (TNFα) and Th17 (producing IL-17, IL-6 and TNFα) T cell lineages. Notably, recent studies have suggested that both Th1 and Th17 cells can independently induce EAE, possibly through different mechanisms 6, 7 . Th17 cells are generated as a discrete lineage following priming in the presence of transforming growth factor β (TGFβ) and IL-6 and acquisition of encephalitogenicity following expansion in the presence of . EAE is markedly suppressed in mice lacking IL-17 or IL-17 receptor (IL-17R), and IL-17-specific inhibition attenuates inflammation, indicating that IL-17-mediated signaling is important during the effector stage of EAE 9,11,12 . However, the precise mechanism by which IL-17 participates in EAE development and pathogenesis remains unclear.
Multiple sclerosis is a T cell-mediated inflammatory demyelinating disease of the human CNS 1 . Inflammatory demyelination is coupled with neurodegeneration in multiple sclerosis, although the precise mechanisms underlying this remain uncertain [2] [3] [4] . Many components of the myelin sheath have been injected into animals to induce EAE. Studies of the EAE model have helped to define the sequence of immunopathogenic events involved in the development of autoimmune CNS-directed inflammatory diseases 5 . During the initiation stage of EAE, in addition to T cell activation and expansion, antigenpresenting cells (APCs) produce cytokines to regulate the differentiation of effector CD4 T cells, including the classical Th1 (producing interferon-γ (IFNγ) and tumor necrosis factor α (TNFα) and Th17 (producing IL-17, IL-6 and TNFα) T cell lineages. Notably, recent studies have suggested that both Th1 and Th17 cells can independently induce EAE, possibly through different mechanisms 6, 7 . Th17 cells are generated as a discrete lineage following priming in the presence of transforming growth factor β (TGFβ) and IL-6 and acquisition of encephalitogenicity following expansion in the presence of IL- 23 (refs. 8-10) . EAE is markedly suppressed in mice lacking IL-17 or IL-17 receptor (IL-17R), and IL-17-specific inhibition attenuates inflammation, indicating that IL-17-mediated signaling is important during the effector stage of EAE 9, 11, 12 . However, the precise mechanism by which IL-17 participates in EAE development and pathogenesis remains unclear.
A two-wave hypothesis has been proposed for the Th17-mediated effector stage of EAE. After priming in peripheral lymph nodes, antigen-specific Th17 cells traffic through the choroid plexus into the subarachnoid space, where they encounter antigen presented by macrophages (meningeal APCs), are restimulated and undergo clonal expansion. As a consequence of productive T cell and APC interactions, Th17 signature cytokines, including IL-17, are produced and impinge on the adjacent CNS tissue. Following activation of the parenchymal vasculature by this cytokine flux, perivascular leukocyte infiltrates accumulate, leading to the explosive inflammatory cascade associated with the onset of EAE. These re-activated Th17 cells subsequently migrate across the glia limitans basement membrane, deep into the parenchymal CNS white matter, and initiate tissue destruction, including demyelination and axonal injury.
Act1 is an essential intracellular adaptor for IL-17 signaling [13] [14] [15] [16] . Considering the importance of Act1 in IL-17 signaling, we used Act1-deficient mice as a model system to investigate the cellular mechanism of IL-17 signaling. Previously, we found that Th17 cells efficiently infiltrate the Act1-deficient CNS, but fail to recruit additional lymphocytes, neutrophils and macrophages from the bloodstream into the CNS, indicating that IL-17-induced Act1-mediated signaling is critical for the conversion of wave 1 to wave 2 during the effector stage of EAE. Notably, targeted Act1 deficiency in neuroectoderm-derived CNS-resident cells (in Nes-cre; Act1 loxP/− mice), but not in endothelial cells or macrophages and microglia, significantly delayed EAE onset and reduced EAE 17 . These data indicate that IL-17 signaling directly to neuroectodermal cells is required for the pathogenic inflammation that occurs during EAE. It is important to note that, although IL-17 signaling activates the transcription factor NF-κB, inhibition of NF-κB in the neuroectodermal cells also ameliorates EAE 18, 19 .
NG2 + glial cells, a distinct macroglial population in the adult CNS that is separate from astrocytes or oligodendrocytes 20 , are closely related 1 4 0 2 VOLUME 16 | NUMBER 10 | OCTOBER 2013 nature neurOSCIenCe a r t I C l e S to progenitors that give rise to myelinating oligodendrocytes during development. Following varied types of CNS injury, NG2 + glia proliferate and have a reactive phenotype that includes increased expression of NG2, a surface proteoglycan. Their fate in vivo thereafter has been a matter of some controversy, but it seems clear that they are involved in myelin repair and mainly give rise to oligodendrocytes 21 . NG2 + glia have not previously been implicated in generating pathogenic inflammatory responses. We sought to define the neuroectodermal cellular target(s) of IL-17 action during EAE. After a series of negative studies, we deleted Act1 from NG2 + glial cells (in NG2 (also known as Cspg4)-cre; Act1 loxP/− mice) and virtually abrogated Th17 cell-induced EAE, recapitulating the EAE phenotype of Nes-cre; Act1 loxP/− mice, which lack Act1 in all neuroectodermal cells 17 . Inflammatory gene expression in response to IL-17 was nearly absent from the CNS of NG2-cre; Act1 loxP/− mice after Th17 cell transfers, accounting for the lack of clinical disease.
RESULTS
Ablation of Act1 from astrocytes modestly reduces EAE Deletion of Act1 in neuroectoderm-derived cells in CNS ameliorated the severity of Th17-induced EAE 17 . Neuroectoderm-derived cells include astrocytes, neurons, NG2 + glia and oligodendrocytes. Astrocytes with processes in the glia limitans and around cerebral blood vessels are positioned to transduce signals from meningeal Th17 cells to activate the blood-brain barrier endothelium and drive perivascular leukocyte infiltration (wave 2) and the consequent explosive inflammatory cascade associated with the onset of EAE. We generated astrocyte-specific Act1-deficient mice, by breeding Act1 −/− mice with Gfap-cre mice to generate Gfap-cre; Act1 +/− mice, and these mice were further bred onto Act1 loxP/loxP mice to generate control mice (Gfap-cre; Act1 loxP/+ ) and astrocyte-specific Act1-deficient mice (Gfap-cre; Act1 loxP/− ). Western analysis revealed that Act1 expression was completely ablated in astrocytes derived from Gfap-cre; Act1 loxP/− mice (Fig. 1a) .
EAE was induced in Gfap-cre; Act1 loxP/− mice and control mice (Gfap-cre; Act1 loxP/+ ) by active immunization with MOG 33−55 . The astrocyte-specific Act1-deficient mice (Gfap-cre; Act1 loxP/− ) showed a delay in the onset and reduced disease severity compared with the control mice (Gfap-cre; Act1 loxP/+ ). However, the EAE phenotype of the astrocyte-specific Act1-deficient mice was not nearly as marked as that of the CNS-restricted Act1-deficient mice (Nes-cre; Act1 loxP/− ; Fig. 1b) 17 . When EAE was induced by adoptive transfer of MOG 35−55 -specific wild-type Th17 cells, the Gfap-cre; Act1 loxP/− mice also showed a modest, but reproducible, reduction in disease severity compared with control mice (Fig. 1c) , whereas the CNS-restricted Act1-deficient mice had delayed onset and greatly reduced EAE (Fig. 1d) . Consistent with reduced clinical disease, mononuclear cell infiltrates were decreased in white matter of spinal cords from Gfap-cre; Act1 loxP/− (Fig. 1e,f) . During EAE, signature IL-17-responsive inflammatory genes (cytokines, chemokines and matrix metalloproteinases) are significantly induced in CNS 2, 22, 23 . Induction of the IL-17-regulated inflammatory genes (including Cxcl1, Cxcl2, Csf2, Il6, Mmp3 and Mmp9) in the spinal cord was substantially reduced in Gfap-cre; Act1 loxP/− mice, somewhat out of proportion to the clinical effect (Fig. 1g) . Overall, our observations were similar to those reported using lentiviral shRNA to reduce Act1 expression in astrocytes 24 . Given that the EAE phenotype of astrocyte-specific Act1-deficient a r t I C l e S mice failed to reproduce that of the CNS-restricted Act1-deficient mice, we can conclude that other neuroectoderm-derived cells must also participate in Th17-mediated EAE pathogenesis.
Neuronal Act1 is dispensable for EAE development A recent study suggested that Th17 cells directly interact with neurons, mediating neuronal dysfunction and contributing to the development of EAE 25 . To determine whether neuronal Act1 is critical for EAE pathogenesis, we generated neuronal Act1-deficient mice by breeding Act1 loxP/− mice with Eno2-cre mice. Western analysis revealed that Act1 expression was abolished in neurons from the resulting Eno2-cre; Act1 loxP/− mice (Fig. 2a) . The onset and disease severity of EAE were similar in Eno2-cre; Act1 loxP/− and Eno2-cre; Act1 loxP/+ mice after either active immunization with MOG 35−55 or adoptive transfer of MOG 35−55 -specific Th17 cells (Fig. 2b,c) . Furthermore, inflammatory cell infiltration in the CNS of the two experimental groups was (Fig. 2d) . Neuronal Act1 deficiency had no substantial effect on inflammatory gene expression in the spinal cords of Th17-induced EAE mice (Fig. 2e) . These data indicate that neuronal Act1 is dispensable for Th17-mediated EAE pathogenesis. A distinct population of glial cells that express the oligodendrocyte progenitor cell (OPC) markers NG2 and PDGFRα persists throughout the adult CNS 20, 26 . These glia (termed NG2 glia or polydendrocytes) can give rise to myelinating oligodendrocytes in vitro or in vivo. They show brisk morphological responses to injury of the CNS. Their physiological roles in the adult CNS have been extensively studied, but remain incompletely understood 21, [27] [28] [29] . We used Ng2-cre mice 20, 30 to mediate specific deletion of Act1 in oligodendrocyte-lineage cells, including developmental OPCs, mature oligodendrocytes and NG2 + glia of the adult CNS. Act1 −/− mice were first bred with NG2-cre mice to generate NG2-cre; Act1 +/− mice. These mice were further bred with Act1 loxP/loxP mice to generate NG2-cre; Act1 loxP/+ and NG2-cre; Act1 loxP/− mice. Immunoblot revealed that Act1 expression was completely ablated in NG2 + cells derived from NG2-cre; Act1 loxP/− mice (Fig. 3a) .
We induced EAE in NG2-cre; Act1 loxP/− mice and control mice (NG2-cre; Act1 loxP/+ ) by active immunization with MOG 33−55 . Notably, Act1 deficiency in NG2 + glia delayed the onset of EAE and greatly reduced the disease severity (Fig. 3b) , similar to NG2-cre; Act1 loxP/− mice. It is important to note that the MOG-induced T cell priming was comparable in NG2-cre; Act1 loxP/− and NG2-cre; Act1 loxP/+ mice (Supplementary Fig. 1b) . Furthermore, Th17 cells from MOGimmunized NG2-cre; Act1 loxP/− and NG2-cre; Act1 loxP/+ mice induced similar EAE in wild-type recipient mice ( Supplementary Fig. 1c-e) . These data suggest that the resistance of NG2-cre; Act1 loxP/− mice to EAE induced by active immunization with MOG 33−55 (Fig. 3b) probably occurred at the effector stage of EAE. To confirm this interpretation, we used both NG2-cre; Act1 loxP/+ and NG2-cre; Act1 loxP/− mice as recipients of activated wild-type MOG 35−55 -specific Th1 or Th17 cells. Although the Th1 cells induced a similar EAE phenotype in both groups of mice, the onset and severity of Th17 cell-induced EAE were greatly reduced in NG2-cre; Act1 loxP/− compared with control mice (Fig. 3c,d) . The NG2-cre; Act1 loxP/− mice had fewer inflammatory cells in the CNS, including CD4 + and CD8 + T cells, macrophages, and neutrophils, than control mice at the peak of disease after Th17 cell transfer (Fig. 3e,f and Supplementary Fig. 1a) . Th17-associated, but not Th1-related, inflammatory gene expression levels in the spinal cords of NG2-cre; Act1 loxP/− mice were markedly reduced compared with control mice (Fig. 3g) . Collectively, these data indicate that, among the neuroectoderm-derived cells, NG2 + glia are important for the occurrence of Th17-mediated EAE.
What is the effect of Act1 deficiency on NG2 + cells and mature oligodendrocytes during EAE? The numbers of NG2 + cells and mature oligodendrocytes were comparable in the spinal cords of naive NG2-cre; Act1 loxP/+ and NG2-cre; Act1 loxP/− mice ( Supplementary  Fig. 2a,b) . Mature GST-π + oligodendrocytes were substantially reduced in the spinal cords of NG2-cre; Act1 loxP/+ mice after EAE induction (Supplementary Fig. 2a) . In contrast, NG2 + cells were markedly increased in NG2-cre; Act1 loxP/+ mice, whereas NG2 + glial cell numbers were unchanged in NG2-cre; Act1 loxP/− mice (Supplementary Fig. 2b) . Consistently, BrdU incorporation in NG2 + cells was much greater in the spinal cords of NG2-cre; Act1 loxP/+ mice than in NG2-cre; Act1 loxP/− mice (Supplementary Fig. 2c ). These results suggest that NG2 + cells were activated during EAE (as evident by increased BrdU incorporation and NG2 + cell numbers), indicating that these cells might participate in the inflammatory cascade that underlies EAE pathogenesis.
However, it is also plausible that the ability of NG2 + glia to participate at later time points in myelin repair might be perturbed by IL-17-induced Act1-mediated signaling, as shown by a decrease in the number of mature oligodendrocytes in NG2-cre; Act1 loxP/+ mice after Th17 EAE induction (Supplementary Fig. 2a) . Notably, following Th1 induction of EAE, both NG2-cre; Act1 loxP/− mice and control mice had similar levels of demyelination, as seen by myelin basic protein (MBP) staining (Supplementary Fig. 2d ).
NG2 + glial cells, a distinct macroglial population in the adult CNS, separate from astrocytes or oligodendrocytes 20 , are closely related to progenitors that give rise to myelinating oligodendrocytes during development or in response to CNS injury. Our results suggest that IL-17 signaling in NG2 + cells might incorporate these glia into the inflammatory pathogenesis of EAE. In particular, the reactive phenotype of increased proliferation and cell number supports this interpretation. However, it is possible that the EAE-resistant phenotype of npg a r t I C l e S NG2-cre; Act1 loxP/− mice could be attributed, in whole or in part, to deletion of Act1 from NG2 + vessel-associated pericytes; thus, we used Olig2-cre mice to mediate the deletion of Act1 in the oligodendrocyte lineage [31] [32] [33] (Supplementary Fig. 3a ). Act1 deficiency in Olig2 + cells delayed the onset of EAE and greatly reduced the disease severity following active immunization with MOG 35−55 (Supplementary Fig. 3b) . Furthermore, the onset and severity of Th17 cell-induced EAE were greatly reduced in Olig2-cre; Act1 loxP/− mice compared with that in control mice, whereas the Th1 cells induced a similar EAE phenotype in both groups of mice ( Supplementary Fig. 3c,d) . The Olig2-cre; Act1 loxP/− mice had fewer inflammatory cells in CNS than control mice at the peak of disease after Th17 cell transfer ( Supplementary  Fig. 3e ). Th17-associated, but not Th1-related, inflammatory gene expression levels in the spinal cords of Olig2-cre; Act1 loxP/− mice were marked reduced compared with control mice ( Supplementary  Fig. 3f ). The EAE phenotypes of Nes-cre; Act1 loxP/− mice, NG2-cre; Act1 loxP/− mice and Olig2-cre; Act1 loxP/− mice were virtually identical, supporting the hypothesis that the neuroepithelial cell whose response to IL-17 was crucial for EAE pathogenesis was the NG2 + glial cell. Given that the NG2-cre transgene mediates deletion of loxP-flanked sequences in oligodendrocyte-lineage cells during development, as well as in the NG2 + glia in the adult, we asked whether mature oligodendrocyte-derived Act1 is important for EAE development. Cnp1 (also known as CNPase) promoter activity is low in OPCs, but gradually increases during oligodendrocyte differentiation and remains high in mature oligodendrocytes 26, 32, 34, 35 . Thus, Cnp1-cre transgenic mice have been invaluable for deleting target genes in mature oligodendrocytes [35] [36] [37] . Immunohistochemical staining revealed that Act1 expression was completely ablated in CNP1 + cells derived from Cnp1-cre; Act1 loxP/− mice (Fig. 4a) . Both immunization with MOG 35−55 and adoptive transfer of activated MOG 35−55 -specific Th17 cells resulted in similar onset and disease severity of EAE in the Cnp1-cre; Act1 loxP/− mice compared with control mice (Fig. 4b,c) . Cell infiltration was also analyzed by flow cytometry after Th17 adoptive transfer. There were comparable levels of cell infiltration in the CNS tissues derived from these two groups of mice (Fig. 4d) . Furthermore, real-time PCR revealed similar levels of induction of inflammatory genes in the spinal cords of Cnp1-cre; Act1 loxP/− mice and Cnp1-cre; Act1 loxP/+ controls (Fig. 4e) . Together, these data indicate that mature oligodendrocytederived Act1 is dispensable for the pathogenesis of EAE.
Inflammatory and cytotoxic effects of IL-17 on NG2 + glia Deletion of Act1 from mature oligodendrocytes had no effect on Th17-mediated EAE, whereas Act1 deficiency in NG2 + glia decisively altered EAE pathogenesis. What responses of NG2 + glia to IL-17 might mediate these effects on EAE severity? To answer this question, we cultured embryonic neurospheres to generate OPCs and mature oligodendrocytes. After 4 d of culture in cytokine cocktail of fibroblast grown factor (FGF) and platelet-derived growth factor (PDGF), the neural stem cells had differentiated into OPCs (>98% Olig2 + CNPase − ). The OPCs were then induced to mature into oligodendrocytes by withdrawing growth factors. At the end of 2 d of maturation, >95% cells were mature oligodendrocytes (CNPase + GFAP − β-tubulin-III − ; Supplementary Fig. 4a,b) . IL-17-induced robust inflammatory responses in OPCs, whereas we detected little inflammatory response in mature oligodendrocytes (Fig. 5a,b) . This inflammatory response in OPCs was Act1 dependent. These results are consistent with our hypothesis that NG2 + glia constitute an essential component of the CNS inflammatory response in Th17-induced EAE. 
r t I C l e S
We also asked whether IL-17 action toward OPCs might affect myelin repair following demyelination. The addition of IL-17 to OPCs from NG2-cre; Act1 loxP/+ mice (Fig. 5c) , but not NG2-cre; Act1 loxP/− mice (Fig. 5d) , substantially reduced the expression of myelin proteins and other markers associated with myelinating oligodendrocytes, suggesting that commitment to an inflammatory program of gene expression might impair the ability of these cells to engage in the process of remyelination. Notably, IL-17 also induced dose-dependent cell apoptosis during the differentiation of OPCs to oligodendrocytes ( Fig. 5e and Supplementary Fig. 4c ), and this effect was abolished in NG2-cre; Act1 loxP/− OPCs (Fig. 5f) . TUNEL assay revealed increased cell death in the parenchyma of spinal cords from NG2-cre; Act1 loxP/+ mice as compared with NG2-cre; Act1 loxP/− mice (43.0 ± 8.3 versus 5.0 ± 3.3 apoptotic cells per section) after Th17 adoptive transfer (Fig. 5g) . Taken together, these data indicate that IL-17 exerts neurotoxic effects on OPCs in vitro and, by extension, could mediate such effects in vivo. As inflammation and neurodegeneration are the cardinal pathogenic processes of multiple sclerosis, these results may have important implications for the human disease. We also examined the effect of IL-17 treatment on cultured astrocytes and neurons. Consistent with our previous findings 17 , although IL-17 induced an inflammatory response in astrocytes from both NG2-cre; Act1 loxP/+ and NG2-cre; Act1 loxP/− mice, neurons from either group of mice were barely responsive to IL-17 (data not shown). It is intriguing to note that IL-17 also induced apoptosis in astrocytes from NG2-cre; Act1 loxP/+ and NG2-cre; Act1 loxP/− mice, indicating that IL-17-induced apoptosis is not restricted to OPCs (data not shown). However, IL-17 stimulation failed to induce apoptosis in neurons (data not shown). Thus, these ex vivo results are consistent with our in vivo EAE phenotypes: although ablation of Act1 from astrocytes modestly reduced autoimmune encephalomyelitis, neuronal Act1 was dispensable for EAE development.
Although much effort has been devoted to the study of IL-17-induced inflammatory response, it is equally important to understand how IL-17 mediates cell apoptosis. Notably, we found that IL-17 induced caspase 3 cleavage in wild-type mouse embryonic fibroblasts (MEFs), but not in Act1-deficient MEFs (Fig. 6a) , confirming that IL-17-induced apoptosis is not restricted to OPCs. Although a recent study suggested that IL-17 can synergize with TNFα to induce apoptosis 38 , we found that TNFα neutralization did not affect IL-17-induced apoptosis in MEFs (Fig. 6b) . Furthermore, IL-17 induced apoptosis in Tnfrsf1a and Tnfrsf1b single and double knockout kidney epithelial cells (Fig. 6c) . These results indicate that IL-17 induces apoptosis independently of TNF-α, but do not answer how Act1 signaling intersects with apoptotic pathways. We found that Act1 interacted with FADD, a death domain-containing adaptor in the cell death pathway (Fig. 6d) . A recent study showed that IL-25 (IL-17E) receptor interacts with the death domain of FADD though the SEFIR domain 39 . Given that Act1 also contains a SEFIR domain and interacts with FADD, we hypothesized that IL-17R might recruit FADD through Act1's SEFIR domain. We found that the SEFIR domain of Act1 was indeed required for its interaction with FADD (Fig. 6d) , and IL-17 failed to induce apoptosis in OPCs from which FADD was depleted by shRNA-mediated knockdown (Fig. 6e) . These data implicate the IL-17R-Act1-FADD axis as a new pathway for cell apoptosis.
DISCUSSION
The mechanisms by which IL-17 contributes to EAE pathogenesis have remained obscure. Previously, we found that targeted Act1 deficiency in neuroectoderm-derived CNS resident cells results in markedly reduced EAE severity 17 , suggesting that IL-17 operates in the CNS to cause disease manifestation. Here, we used genetic models to address the cellular basis of this observation. We abrogated IL-17 signaling in astrocytes, oligodendroglial-lineage cells or neurons to directly examine how Th17-mediated demyelination and neurodegeneration proceed during EAE. Several notable observations emerged during these experiments. First, our results provide definitive genetic evidence that IL-17 signaling to Act1 in astrocytes has only a modest role in the severity of EAE. Given that GFAP is also expressed by a small fraction of neural stem cells, it is possible that GFAP + stem cell-derived NG2 + glia might partially account for the phenotype observed in Gfap-cre; Act1 loxP/− mice. However, western analysis revealed that the sorted NG2 + glial cells from both Gfap-cre; Act1 loxP/− and Gfap-cre; Act1 loxP/+ mice had similar levels of Act1 (data not shown). Thus, the reduced EAE phenotype observed in Gfap-cre; Act1 loxP/− mice is probably a result of the reduced inflammatory response of the astrocytes in these mice. Notably, the deletion of Act1 from NG2 + glial cells markedly reduced the severity of Th17 cell-induced EAE and recapitulated the npg a r t I C l e S and Cxcl2, but we found no effect on the IFN-γ-induced chemokines CXCL9 and CXCL10. The same gene expression pattern was observed in vitro using cells derived from these mice. These results identify a previously unknown CNS-resident cellular target for IL-17-mediated EAE pathogenesis. It has been remarked on several occasions that NG2 + glia show morphological transformation in response to inflammation 40, 41 . To date, the microglia and astrocytes have been considered to be the major reactive glial elements of the CNS. Our results represent, to the best of our knowledge, the first insight into specific pathogenic effects of NG2 + glial cell neuroinflammation. Consistent with the in vivo EAE phenotype, IL-17 induced inflammatory gene expression in OPCs derived in vitro from neurosphere cells. Although NG2 + cells are also referred to as OPCs, about 85% of the cultured OPCs are NG2 + cells in our culture system. Together with our in vivo findings, the observed IL-17-induced inflammatory response in OPCs strongly supports the interpretation that NG2 + cells in vivo are involved in IL-17-dependent inflammatory response during EAE. In support of this, we found that NG2-cre-mediated Act1 deletion substantially reduced Th17-induced inflammatory gene expression in the spinal cord during EAE. Eliminating Act1 signaling from GFAP + astrocytes also moderately reduced the severity of EAE and lessened expression of Th17-associated, but not Th1-associated, chemokines. Comparable effects were recently obtained by intrathecal lentiviral delivery of Act1 shRNA using an expression cassette that targeted astrocytes 24 .
Multiple sclerosis (and the EAE model) results in both inflammatory and neurodegenerative damage to the CNS tissue. The relationship between inflammation and neurodegeneration has been controversial and difficult to resolve. Recent important reports have suggested that removal of myelin renders axons metabolically nonviable, placing intense emphasis on understanding mechanisms by which myelin repair either occurs or fails 42, 43 . We also found that IL-17 affected survival and maturation of OPCs derived in vitro from neurosphere cells. Following varied types of CNS injury, NG2 + glia proliferate and are involved in myelin repair and mainly give rise to oligodendrocytes 21 . We found that, although NG2 + cells were indeed activated during EAE (as evident by increased BrdU incorporation and NG2 + cell numbers), mature oligodendrocytes were substantially reduced in the spinal cords of NG2-cre; Act1 loxP/+ mice compared with those in NG2-cre; Act1 loxP/− mice. These results suggest that the NG2 + glia may indeed function as precursors and progenitors (OPCs) in vivo and their ability to participate in the repair of demyelination might be perturbed by IL-17-induced Act1-mediated signaling. Taken together, these ex vivo and in vivo observations suggest that IL-17 mediates neurotoxic effects toward NG2 glia in EAE, in addition to eliciting pronounced pathogenic inflammatory responses from these cells. Impaired remyelination has marked consequence for the progressive loss of demyelinated axons and functional deficits. The remyelination process involves the proliferation and maturation of NG2 cells, which are widely distributed through adult CNS and remain committed to the oligodendrocyte lineage 44, 45 .
The importance of cell apoptosis in the pathogenesis of EAE has been extensively studied. Both extrinsic and intrinsic pathways of apoptosis affect EAE development [46] [47] [48] [49] . The death of oligodendrocytes not only causes direct demyelination, but also releases danger signals that further induce sterile inflammation. Moreover, the debris from the dead cells provides abundant self-antigens that continuously reactivate infiltrated T cells. Thus, inflammation and cell death constitute a positive feedback loop in CNS autoimmune inflammation 50 .
In conclusion, our in vitro data suggest that IL-17 has neurotoxic effects and is involved in the pathogenesis of EAE, which is supported by our observation of increased numbers of apoptotic cells in tissue from EAE mice with intact Act1 signaling in NG2 + glia. Taken together, our data suggest that the immune and neurotoxic effects of IL-17 toward glial cells (predominantly NG2 + glia) provide a crucial link joining the inflammatory and neurodegenerative aspects of multiple sclerosis.
METHODS
Methods and any associated references are available in the online version of the paper. 
